Joshua Muia: Our Latest Review on the Proatherogenic Metalloprotease ADAMTS7
Joshua Muia, Associate Investigator at Versiti Blood Research Institute, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Thrilled to share our newly published review on the proatherogenic metalloprotease ADAMTS7!
Proud of the incredible effort by trainees in my lab, working together with medical students and postdoctoral fellows across Oklahoma State University Center for Health Sciences, National Eye Institute (NIH), Georgetown University Medical Center, and Versiti Blood Research Institute.”
Title: The biology and pathophysiology of the proatherogenic metalloprotease ADAMTS7
Authors: Shiwali Goyal, James Muniu, Mohd Akbar Bhat, Eli Oldham, Derrick Pruitt, Luis Frias Perez, Frida Miranda, Joshua Muia
Read the Full Article on Open Biology
Stay updated on all scientific advances with Hemostasis Today.
-
May 22, 2026, 13:53Masoabi Sefojane: The Structural Invisibility of Bleeding Disorders in the Global South
-
May 22, 2026, 13:41Ney Carter Borges: New Trial Highlights IVL as Effective Strategy for Calcified Coronary Lesions
-
May 22, 2026, 13:36Ajay Samkaria։ A Compatible Crossmatch Does Not Always Mean Complete Safety
-
May 22, 2026, 13:31Mariam Swidan: Why Hemolysis Severity Matters in G6PD Deficiency
-
May 22, 2026, 13:25Augustina Isioma Ikusemoro: Why Plasma and RBC Transfusions Follow Different Compatibility Rules
-
May 22, 2026, 13:08Anas Hamad: Thrombosis as Overlooked Clinical Challenge in APL
-
May 22, 2026, 12:29Neema Ngugi: Highlighting 6 Major Types of Anemia
-
May 22, 2026, 12:27Jacinto López Sagaseta: Solving the Structural Puzzle of FVIIa–EPCR Interaction
-
May 22, 2026, 12:25Shehab Mohamed: Exploring the Emerging Link Between JAK2 Mutations and Thoracic Aortic Aneurysms